CompuGroup Medical Aligns With CVC in Strategic Partnership
Deal News | Dec 09, 2024 | CVC Capital Partners
CompuGroup Medical SE & Co. KGaA, a leading e-health provider, has entered into a strategic partnership with CVC Capital Partners, one of the premier private equity firms globally. The partnership entails CVC launching a voluntary public tender offer of EUR 22.00 per share, which represents a 51.1% premium to the three-month volume-weighted average price. This move is expected to complement CompuGroup Medical's long-term growth and innovation strategy by leveraging CVC's extensive expertise in healthcare and software investments. The founding family, including Frank Gotthardt and Dr. Daniel Gotthardt, will maintain their majority stake, ensuring ongoing family leadership and stability. This partnership aims to advance CompuGroup Medical's mission of enhancing healthcare via digitalization, focusing on cutting-edge, data-driven, AI-powered solutions for medical professionals. CompuGroup Medical's alignment with CVC reflects the evolving demands within the healthcare sector, which necessitate enhanced digital solutions amid demographic shifts and workforce shortages.
Sectors
- Healthcare Technology
- Private Equity
Geography
- Germany – CompuGroup Medical, a leading e-health provider, is based in Koblenz, Germany, and much of the strategic relevance is tied to its European operations.
- Europe – The partnership's impact and strategic goals are designed to enhance healthcare innovation across Europe, per statements by key figures involved.
Industry
- Healthcare Technology – The article extensively discusses CompuGroup Medical's role in healthcare digitalization and its strategic partnership to enhance digital healthcare solutions.
- Private Equity – CVC Capital Partners, a leading private equity firm, is playing a crucial role in the strategic investment and partnership with CompuGroup Medical.
Financials
- EUR 22.00 per share – The price per share offered by CVC Capital Partners in the tender offer for CompuGroup Medical's shares.
- 51.1% premium – The premium offered by CVC Capital Partners over CompuGroup Medical's 3-month volume-weighted average price.
Participants
Name | Role | Type | Description |
---|---|---|---|
CompuGroup Medical SE & Co. KGaA | Target Company | Company | CompuGroup Medical is a global e-health provider focused on digital healthcare solutions. |
CVC Capital Partners | Bidding Company | PE Firm | CVC Capital Partners is a leading private equity firm looking to acquire a strategic stake in CompuGroup Medical through a tender offer. |
GT1 Vermögensverwaltung GmbH | Majority Shareholder | Company | The investment management firm representing the interests of the majority stakeholders in CompuGroup Medical. |
Frank Gotthardt | Chairman of Administrative Board | Person | Founder and Chairman of the Administrative Board at CompuGroup Medical. |
Dr. med. Daniel Gotthardt | CEO | Person | Chief Executive Officer and member of the Administrative Board at CompuGroup Medical. |
Dr. Reinhard Koop | Shareholder | Person | Related shareholder holding part of the majority stake along with the Gotthardt family. |
Daniela Hommel | CFO | Person | CFO at CompuGroup Medical, commenting on the strategic partnership benefits. |
Daniel Pindur | Managing Partner | Person | Managing Partner at CVC Capital Partners, articulating the partnership's strategic vision. |
Can Toygar | Senior Managing Director | Person | Senior Managing Director at CVC, discussing the healthcare market's digital needs. |